Circulating levels of BMP9 were found to be decreased in PoPH patients compared to healthy individuals or those with other etiologies of PAH, suggesting BMP9 as a potential biomarker for PoPH [165]. This evidence concerns the gene GDF2 and Pulmonary arterial hypertension associated with portal hypertension.